ArticleJournal of patient experience2025
Let's Talk About Myopia: Literature Review and Stakeholder Survey to Develop a Roadmap for Advocacy.
Article in Journal of patient experience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The "Three-Tier Regulatory Network" of Orthokeratology in Myopia Control: Evidence Weight of Underlying Mechanisms, Controversies, and New Perspectives for Clinical Translation--A Review.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myopia (short-sightedness) in children is a public health concern, as prevalence and severity are rising. By 2050, half the world population may have myopia, with a fifth at risk of uncorrectable sight-loss. Effective treatments to slow the worsening of myopia are not publicly funded. Here we aimed to complete the first 2 of these stages of designing an effective myopia advocacy campaign, that is, issue identification and research/analysis. We carried out a literature review on myopia/eye care advocacy campaigns and an online key stakeholder survey with exploratory open-ended questions distributed to a convenience sample of 30 individuals known from previous informal discussions, including parents, a young adult, facilitators/representatives of UK and European myopia patient advocacy groups/charities, professional organizations and industry. We extracted data from included publications into a prespecified table and used thematic analysis to summarize survey responses. The main issues identified are perceived lack of public/professional awareness, complications and interventions, and public funding. The most important rationales for eye-healthy behavior and interventions are: short/medium-term improvement in quality of life linked to lower levels of short-sightedness, and long-term reduction of risk of sight-threatening complications and healthcare costs. A myopia advocacy campaign should increase public/professional awareness, provide education and information for eye/healthcare practitioners, families, teachers and other professionals, lead to public funding, and promote collaborations between stakeholders to enable funding for appropriate interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.